Imricor Announces Sales Agreement with NordicNeuroLab

30 August 2021 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce it has entered into a Sales Distribution Agreement with NordicNeuroLab AS, a leading maker of MRI compatible in-room monitors, headquartered in Norway.

Under the terms of the agreement, Imricor will be a non-exclusive distributor of NordicNeuroLab’s InroomViewingDevice. The InroomViewingDevice is a high quality 40” MRI-compatible monitor for use in the magnet room of an iCMR lab.

Imricor’s Chair and CEO, Steve Wedan, said: “NordicNeuroLab is an established world leader in providing solutions for functional MRI imaging (fMRI) applications, and one component of their product set is an MRI compatible in-room monitor that is very well suited for iCMR labs. Imricor has two of these monitors installed in our own iCMR Design Center, and many of our customers have also chosen these monitors for their iCMR labs.

“The agreement with NordicNeuroLab streamlines the sales process for all parties and strengthens the range of 3rd party iCMR lab equipment Imricor offers to its customers.”

Thomas Lie Omdahl, CEO of NordicNeuroLab, said: “We are very excited to be partnering with the first and only company in the world to bring commercially viable and safe iCMR products to the catheter ablation market. The partnership with Imricor allows us to further expand the utilization of certain fMRI peripherals, such as the InroomViewingDevice, to benefit more patients and clinicians worldwide.”

~ ~ ~ ~ ~
About Imricor